Highlights: GLP-1 receptor agonists were associated with a slightly higher relative risk of nonarteritic anterior ischemic optic neuropathy (NAION) , although the one-year absolute risk remained only 0.04% A nationwide Swedish cohort study followed more than 293,000 adults with type 2 diabetes who started GLP-1 receptor agonists or SGLT-2 inhibitors
Personally, my "gut" is telling me they'll probably be absolutely fine, but might see if the nice folk at Bodfeld can send me some new ones
Tesamorelin targets visceral fat directly through GH-driven lipolysis without affecting appetite or total body weight substantially
Ketosis was not seen at baseline
This formulation bypasses reconstitution steps and supports consistent delivery for advanced regenerative, vascular, and musculoskeletal studies
Understanding this timeline helps patients and clinicians anticipate and manage adverse reactions appropriately